Jalupro treatment protocols and <i>emotional wellbeing in women aged 55–65</i>: a mixed methods case study series

Background: Self-esteem and ageing are closely linked. In an image-saturated media environment, mature women increasingly seek aesthetic and regenerative treatments to maintain agency and alignment between inner and outer self. Psychological outcomes of such interventions remain under-reported. Methods: Prospective mixed-methods observational case series in a medically led clinic (n=6; women aged 55–65). Participants underwent a structured protocol with Jalupro ® formulations; Young Eye, HMW and Super Hydro (using the LIFT protocol) across four monthly sessions, plus adjunct mask and LED. Outcomes: objective skin analysis (scanner) and validated questionnaires (adapted Facial Esteem Scale, Rosenberg Self-Esteem Scale, SPANE, SWLS) at baseline and 2 months post-treatment. Semi-structured interviews were analysed inductively. Descriptive statistics and Cohen's d were calculated. Results: Psychometrics showed group-level gains: Facial Esteem +36% (d=1.09); Rosenberg +13% (d=0.80); SPANE +14% (d=0.25); SWLS +2% (d=0.15). Mean individual % change was higher for Facial Esteem (+43.1%) and SPANE (+45.7%), indicating heterogeneous responses and larger improvements among those with lower baselines. Scanner data suggested improvements most consistently in wrinkles (−15.8%) and pores (−9.9%). Qualitative themes: stronger psychological benefit when concerns were selfidentified; discomfort common yet tolerated; unsolicited compliments reinforced satisfaction. One non-responder showed limited change across modalities. Conclusions: In mature women, a structured Jalupro ® protocol was associated with meaningful improvements in facial self-esteem and modest gains in broader wellbeing, alongside objective improvements in wrinkle and pore metrics. Correlation between objective and psychological outcomes was evident but varied in magnitude. Findings support person-centred assessment, motivation-focused consultation, and multimodal outcome evaluation. Larger controlled studies with validated imaging and longer follow-up are warranted.